Screening, intervention of sleep disorders in children also benefits parents

Article

 

Sleep disorders in children are commonly screened via the BEARS (Bedtime, Excessive daytime sleepiness, Awakening during the night, Regularity and duration of sleep, Snoring) questionnaire. Now investigators have shown that long-term benefits are seen through regular screening and timely interventions not only for children, but also for their parents.

Investigators examined the parentally perceived prevalence of sleep disorders in the pediatric waiting rooms of 2 family health centers. Parents filled out an anonymous modified BEARS questionnaire per child that asked whether they believed that a sleep disorder was present and if the perceived disorder affected their child’s health or family life.

In 300 surveys collected from both sites, parents reported the sleep disorders present or affecting family life as bedtime problems, excessive daytime sleepiness, nocturnal awakenings, poor regularity of sleep, and snoring. Irregular sleep was reported by 21.3% and snoring by 13.7%; both problems were reported by 5% of parents as affecting family life.

The American Academy of Pediatrics recommends screening for pediatric sleep disorders by clinicians because parents may describe any sleep problem, particularly those disturbing their own sleep, as a disorder.

Krishna J, Lonzer D, Medina M. Parental perception of sleep disorders in urban family health centers in the greater Cleveland area. Sleep. 2013;36(Suppl):A349-A350. Abstract 1019.

Recent Videos
cUTI Roundtable: Discussing and diagnosing these difficult infections
Willough Jenkins, MD
Discussing health care sustainability, climate change, and WHO's One Health goal | Image credit: Provided by Shreya Doshi
Willough Jenkins, MD
Screening for and treating the metatarsus adductus foot deformity |  Image Credit: UNFO md ltd
Wendy Ripple, MD
Wendy Ripple, MD
Courtney Nelson, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.